Sign up to The Irish Times Archive (1859 - 2008)My Account »
Mon 11 Nov 2008New breast-cancer drug unveiled in Cork
A new breast cancer therapy that is made in Cork and trialled in Ireland was unveiled today.
Lapatinib (market name TyverbR) targets a type of breast cancer known as ErbB2-positive that accounts for about 25-30 per cent of all breast cancers. It is prescribed for use in women with advanced breast cancer who have exhausted all other therapeutic options.
Choose a Subscription type - required
